Paid Clinical Trials Everett

Discover 930 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 930

Proactive-HF-2PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Recruiting

Sponsor:

Endotronix, Inc.

Location:

Everett WA, Portland OR, San Francisco CA, Los Angeles CAshow 35 more

Code:

NCT05934487

Conditions

Heart Failure NYHA Class II

Heart Failure NYHA Class III

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cordella™ Pulmonary Artery Sensor System

LumateperoneSafety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder

Recruiting

PHASE1

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Everett WA, Lincoln NE, Saint Charles MO, Atlanta GAshow 4 more

Code:

NCT06557902

Conditions

Autism Spectrum Disorder

Eligibility Criteria

Sex: All

Age: 5 - 12

Healthy Volunteers: Not accepted

Interventions

Lumateperone 10.5 mg capsule

Lumateperone 21 mg capsule

Lumateperone 5 mg ODT

Lumateperone 10.5 mg ODT

Lumateperone 15.5 mg ODT

Observational StudyC-Brace Prospective Registry

Recruiting

Sponsor:

Otto Bock Healthcare Products GmbH

Location:

Everett WA, Renton WA, Spokane WA, Saint George UTshow 47 more

Code:

NCT04640584

Conditions

Pareses

Lower Extremity

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

C-Brace

LUT014LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

Recruiting

PHASE2

Sponsor:

Lutris Pharma Ltd.

Location:

Everett WA, Tacoma WA, Glendale CA, Santa Monica CAshow 11 more

Code:

NCT04759664

Conditions

EGFRI Induced Acneiform Lesions

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LUT014 Gel (Dose 1)

LUT014 Gel (Dose 2)

Placebo

NBI-1065845Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Recruiting

PHASE3

Sponsor:

Neurocrine Biosciences

Location:

Everett WA, Orange CA, Avon Lake OH, Watertown MAshow 2 more

Code:

NCT06786624

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NBI-1065845

Placebo

TelemedicineThe TELENEO Trial: a Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

Recruiting

Sponsor:

Mayo Clinic

Location:

Everett WA, Seattle WA, Anacortes WA, Port Angeles WAshow 24 more

Code:

NCT06087224

Conditions

Death; Neonatal

Morbidity;Newborn

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Teleneonatology

Observational StudyThe Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19

Recruiting

Sponsor:

N5 Sensors

Location:

Everett WA

Code:

NCT06571136

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Accepted

AzetukalnerA Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Recruiting

PHASE3

Sponsor:

Xenon Pharmaceuticals Inc.

Location:

Everett WA, Walnut Creek CA, Las Vegas NV, Torrance CAshow 15 more

Code:

NCT06775379

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Azetukalner

Placebo

Weight GainStudy to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Recruiting

PHASE3

Sponsor:

Alkermes, Inc.

Location:

Everett WA, Stanford CA, Encino CA, Upland CAshow 19 more

Code:

NCT05303064

Conditions

Schizophrenia

Bipolar I Disorder

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

OLZ/SAM

Olanzapine

Disitamab Vedotin vs ChemotherapyDisitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Recruiting

PHASE3

Sponsor:

Seagen Inc.

Location:

Everett WA, Seattle WA, Vancouver, Calgaryshow 34 more

Code:

NCT05911295

Conditions

Urothelial Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

disitamab vedotin

pembrolizumab

gemcitabine

cisplatin

carboplatin